VLS-1488

Volastra Therapeutics, Inc. · Phase 1 active Small molecule

At a glance

Generic name	VLS-1488
Sponsor	Volastra Therapeutics, Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

VLS-1488 CI brief — competitive landscape report
VLS-1488 updates RSS · CI watch RSS
Volastra Therapeutics, Inc. portfolio CI